AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Resmed DRC

37.380

+0.1100.30%

Volume:936.64K

Turnover:34.93M

Market Cap:54.48B

PE:2.53

High:37.380

Open:37.310

Low:37.060

Close:37.270

52wk High:45.141

52wk Low:31.825

Shares:1.46B

Float Shares:145.49M

Volume Ratio:0.89

T/O Rate:0.64%

Dividend:0.33

Dividend Rate:0.89%

EPS(TTM):14.761

EPS(LYR):14.423

ROE:25.41%

ROA:14.18%

PB:5.89

PE(LYR):2.59

Loading ...

Overview Company News Filings

Weekly Wrap: Will the ASX 200 Break Records? Investors Hope for Continued Momentum

ResMed Chief Legal Officer Sells Shares

MT Newswires Live

Auscap’s case for active investing and where they’re finding value

ResMed Bull Likes Medium-Term Margin Prospects -- Market Talk

ResMed Initiated at Buy by Citigroup

Will Mumford’s go to metric for finding high-quality stocks

Innovation or illusion? How to spot the real disruptors (and 4 ASX ideas for your trouble)

Schroders warn of frothy markets despite ASX highs

ASX reporting season: Margins, misses, and market opportunities

ResMed Inc. Stock Rises Thursday, Outperforms Market

ResMed Inc. Stock Falls Wednesday, Underperforms Market

ResMed CEO Sells $2.2 Million in Shares

MT Newswires Live

ResMed Inc. Stock Rises Thursday, Outperforms Market

ResMed Starts Clinical Insights Initiative to Understand Sleep Health

MT Newswires Live

ResMed on Track for Longest Losing Streak Since May 2022 -- Data Talk

ResMed CFO Sells Shares

MT Newswires Live

ResMed Inc. Stock Falls Tuesday, Underperforms Market

ResMed Inc. Stock Falls Thursday, Underperforms Market

ResMed Inc. Stock Falls Monday, Underperforms Market

ResMed Inc. Stock Rises Wednesday, Outperforms Market

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RMD.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RMD.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RMD.AU\",,,,,undefined,":{"symbol":"RMD.AU","market":"AU","secType":"STK","nameCN":"Resmed DRC","latestPrice":37.38,"timestamp":1766034720000,"preClose":37.27,"halted":0,"volume":936643,"delay":0,"nameEN":"Resmed DRC","floatShares":145494856,"shares":1457529700,"eps":14.76114737727876,"marketStatus":"Not Yet Opened","change":0.11,"latestTime":"12-18 16:12:00 AEDT","open":37.31,"high":37.38,"low":37.06,"amount":34926543,"amplitude":0.008586,"askPrice":37.6,"askSize":536,"bidPrice":37.27,"bidSize":500,"shortable":3,"etf":0,"ttmEps":14.76114737727876,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1766098800000},"marketStatusCode":0,"adr":0,"adrRate":1,"exchange":"ASX","adjPreClose":37.27,"dividendRate":0.008863,"openAndCloseTimeList":[[1766012400000,1766034000000]],"volumeRatio":0.885357,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RMD.AU\",,,,,undefined,":{"symbol":"RMD.AU","floatShares":145494856,"roa":"14.18%","roe":"25.41%","lyrEps":14.4233,"volumeRatio":0.885357,"shares":1457529700,"dividePrice":0.3313,"high":37.38,"amplitude":0.008586,"preClose":37.27,"low":37.06,"week52Low":31.825,"pbRate":"5.89","psRate":"6.86","week52High":45.141,"institutionHeld":0,"latestPrice":37.38,"committee":-0.034749,"eps":14.76114737727876,"divideRate":0.008863,"volume":936643,"delay":0,"ttmEps":14.76114737727876,"open":37.31,"prevYearClose":36.444,"prevWeekClose":37.91,"prevMonthClose":39.31,"prevQuarterClose":40.932,"fiveDayClose":37.87,"twentyDayClose":37.76,"sixtyDayClose":40.493,"dividendPayoutRate":0.022447131800316125,"dividendGrowthYears":1,"dividendGrowthRate":0.09979072881549825,"fiveYearAvgDividendRate":0.011853610951582185},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RMD.AU\",params:#limit:5,,,undefined,":[{"date":"2025-11-12","symbol":"RMD.AU","amount":0.06,"announcedDate":"2025-10-31","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-11-13","name":"Resmed DRC","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-18","payableDate":"2025-11-13","currency":"USD","dateTimestamp":1762866000000,"payDate":"2025-12-18"},{"date":"2025-08-13","symbol":"RMD.AU","amount":0.06,"announcedDate":"2025-08-01","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-08-14","defaultRemindTime":1755043200000,"name":"Resmed DRC","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-18","payableDate":"2025-08-14","currency":"USD","dateTimestamp":1755007200000,"payDate":"2025-09-18"},{"date":"2025-05-07","symbol":"RMD.AU","amount":0.053,"announcedDate":"2025-04-24","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-05-08","defaultRemindTime":1746576000000,"name":"Resmed DRC","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-12","payableDate":"2025-05-08","currency":"USD","dateTimestamp":1746540000000,"payDate":"2025-06-12"},{"date":"2025-02-12","symbol":"RMD.AU","amount":0.053,"announcedDate":"2025-01-31","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-02-13","name":"Resmed DRC","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-20","payableDate":"2025-02-13","currency":"USD","dateTimestamp":1739278800000,"payDate":"2025-03-20"},{"date":"2024-11-06","symbol":"RMD.AU","amount":0.053,"announcedDate":"2024-10-25","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-11-07","name":"Resmed DRC","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-12","payableDate":"2024-11-07","currency":"USD","dateTimestamp":1730811600000,"payDate":"2024-12-12"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RMD.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-08-19","recordDate":"2020-08-20","paymentDate":"2020-09-24","value":0.039,"currency":"USD"},{"executeDate":"2020-11-11","recordDate":"2020-11-12","paymentDate":"2020-12-17","value":0.039,"currency":"USD"},{"executeDate":"2021-02-10","recordDate":"2021-02-11","paymentDate":"2021-03-18","value":0.039,"currency":"USD"},{"executeDate":"2021-05-12","recordDate":"2021-05-13","paymentDate":"2021-06-17","value":0.039,"currency":"USD"},{"executeDate":"2021-08-18","recordDate":"2021-08-19","paymentDate":"2021-09-23","value":0.042,"currency":"USD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RMD.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2572555996","title":"Weekly Wrap: Will the ASX 200 Break Records? Investors Hope for Continued Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2572555996","media":"Small Caps","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572555996?lang=en_us&edition=fundamental","pubTime":"2025-10-03 22:06","pubTimestamp":1759500367,"startTime":"0","endTime":"0","summary":"The Australian share market overcame a poor start to rise and salutes the end of the week on Friday, well within reach of record highs.A broad rally in sectors such as healthcare, IT, consumer discretionary and real estate stocks helped to overcome weakness in energy and utilities, helping the ASX 200 to rise by 0.5% or 41.5 points to close at 8987.4 points.That is not far off the record close of 9019.2 points set in August – a level that could be eclipsed in the coming week if the positive trend continues.There is a chance of that as investors continue to see signs of profit growth locally and offshore, with the chance of interest rate cuts coming down the track.Although there is plenty to worry about as well, with the United States once again “enjoying” another public service shutdown of unknown duration and no shortage of doomsayers warning of an AI investment overshoot and rising unemployment.It was a good day too for shareholders in Mesoblast  as the stock added 8.7% t","market":"hk","thumbnail":"https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/10/featured-1759499950581.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/10/featured-1759499950581.jpg"],"rights":{"source":"smallcap_stock","url":"https://smallcaps.com.au/will-the-asx-200-break-records-investors-hope-for-continued-momentum/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://smallcaps.com.au/will-the-asx-200-break-records-investors-hope-for-continued-momentum/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"smallcap_stock","symbols":["BK7136","BK7503","BK7143","WDS.AU","BK7511","RMD.AU","360.AU","BK4211","BK7158","DGT.AU","AGL.AU","RHC.AU","STO.AU","APX.AU","RMS.AU","BK7061","BK7506","MSB.AU","TLS.AU","BK7166","BK7007","BK7501","BK7067","BK7104","BK7042","EVN.AU","BK7113","BK7507","ISBC","BK7016","BK7094","APE.AU","BK7142","HOPE","BK7508","XYZ.AU","CSL.AU","NST.AU","PME.AU"],"gpt_icon":0},{"id":"2572983566","title":"ResMed Chief Legal Officer Sells Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2572983566","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572983566?lang=en_us&edition=fundamental","pubTime":"2025-10-02 07:17","pubTimestamp":1759360652,"startTime":"0","endTime":"0","summary":"ResMed (ASX:RMD) Chief Legal Officer Michael Rider sold 100 shares on the New York Stock Exchange for $27,436 in total, according to a Thursday filing with the Australian bourse.Following the sale of shares, Rider owns 146.4 million shares in the company, per the filing.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4504","IE00B5TLWC47.USD","BK4567","XAO.AU","BK7007","BK4585","BK4082","BK4588","RMD.AU","XKO.AU","XJO.AU","LU0170899867.USD","LU2177674079.SGD","BK7501","RMD","BK4548","LU2008162690.USD"],"gpt_icon":0},{"id":"2571878200","title":"Auscap’s case for active investing and where they’re finding value","url":"https://stock-news.laohu8.com/highlight/detail?id=2571878200","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571878200?lang=en_us&edition=fundamental","pubTime":"2025-09-29 07:30","pubTimestamp":1759102202,"startTime":"0","endTime":"0","summary":"The debate between passive and active investing is not likely to be settled anytime soon.However, if you listen to Tim Carleton of Auscap Asset Management, a Sydney-based fund manager that focuses on quality and value, perhaps it is not a question about which is better, but what is best for a particular environment.According to Carleton, it all comes down to what you are investing in.When you invest in an index, you’re going to be biased or overweight towards the largest companies in that index. He argues that if those are the companies that are delivering the best earnings growth, then this is a great market to be passively invested in.When Auscap looks at the All Ordinaries Index, they are not seeing a market that is good for passive investing.According to Carleton, the All Ordinaries is dominated by low-growth companies that are facing structural, cyclical, or other challenges.Once something investors feared, GLP-1 medications, such as Ozempic, are reportedly increasing the diagnosi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/auscap-s-case-for-active-investing-and-where-they-re-finding-value","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/auscap-s-case-for-active-investing-and-where-they-re-finding-value","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["BK7107","BK7132","NCK.AU","RMD.AU","XKO.AU","BK7005","SHL.AU","APE.AU","BK7007","BK7511","BK7143","XJO.AU","BK7124","MQG.AU","BK7501","BK7046","XAO.AU","BK7162","HDN.AU","IEL.AU"],"gpt_icon":0},{"id":"2568081236","title":"ResMed Bull Likes Medium-Term Margin Prospects -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2568081236","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568081236?lang=en_us&edition=fundamental","pubTime":"2025-09-19 11:57","pubTimestamp":1758254220,"startTime":"0","endTime":"0","summary":"0357 GMT - ResMed's bull at Citi thinks the market is underestimating the breath-tech provider's medium-term margin-expansion capacity. Analyst Laura Sutcliffe points out that consensus for a fiscal 2026 gross margin of 62% is in-line with guidance, but ignores management's later growth ambitions. She thinks that 63% is achievable in fiscal 2027 and beyond. A good performance through fiscal 2026 could prompt analysts to rerate the stock, she writes in a note. Citi initiates coverage of ResMed's U.S.-listed stock with a US$330.00 target price and a buy rating. It also rated ResMed's Australia-listed stock a buy, and lifts its target price 4.1% to A$51.00. ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","RMD.AU","LU2008162690.USD","LU2177674079.SGD","BK4567","LU0170899867.USD","RMD","BK4585","BK7501","BK4588","BK4082","BK7007","BK4504","IE00B5TLWC47.USD"],"gpt_icon":0},{"id":"2568247160","title":"ResMed Initiated at Buy by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2568247160","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568247160?lang=en_us&edition=fundamental","pubTime":"2025-09-18 19:30","pubTimestamp":1758195000,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RMD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 18, 2025 07:30 ET (11:30 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0170899867.USD","LU2177674079.SGD","LU2008162690.USD","BK4504","BK4548","BK7007","BK7501","BK4082","BK4585","IE00B5TLWC47.USD","BK4567","BK4588","RMD","RMD.AU"],"gpt_icon":0},{"id":"2567014207","title":"Will Mumford’s go to metric for finding high-quality stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2567014207","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567014207?lang=en_us&edition=fundamental","pubTime":"2025-09-16 04:00","pubTimestamp":1757966413,"startTime":"0","endTime":"0","summary":"What’s the first thing you look at to figure out if a company is high-quality?Return-on-equity, margins or perhaps its a qualitative factor like customer retention.Will Mumford, Deputy Portfolio Manager at Auscap Asset Management, says he looks for long-term earnings growth as the best litmus test for identifying quality.Will Mumford: I’d say neutral overall. The market’s P/E multiple is historically high - that’s clear. But within the market there’s a lot of variability. Some sectors are cheap, and interestingly, those aren’t necessarily the lower-quality areas. That creates opportunities.Will Mumford:I’d call out Eagers Automotive . Every time we meet with them, they’ve got a new initiative that could be a game changer. Not everything works — for example, the plan to consolidate dealerships at Brisbane Airport fell through. But their joint venture with B","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/will-mumford-s-go-to-metric-for-finding-high-quality-stocks","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/will-mumford-s-go-to-metric-for-finding-high-quality-stocks","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["BK7143","APE.AU","BK7501","BK7007","RMD.AU"],"gpt_icon":0},{"id":"2567150249","title":"Innovation or illusion? How to spot the real disruptors (and 4 ASX ideas for your trouble)","url":"https://stock-news.laohu8.com/highlight/detail?id=2567150249","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567150249?lang=en_us&edition=fundamental","pubTime":"2025-09-15 04:00","pubTimestamp":1757880037,"startTime":"0","endTime":"0","summary":"We all love a compelling growth story, but how do you tell whether you're buying substance or sizzle?In this episode, we’re diving into one of the most exciting - and sometimes most dangerous - areas of the market: innovation.It’s a word that gets thrown around a lot, but how do you tell the difference between a company with a slick marketing pitch and one that’s genuinely building something transformative?To unpack this, Livewire's Chris Conwayisjoined by Steve Johnson from Forager and Martin Hickson from 1851 Capital.Johnson and Hickson share what innovation means to them, the traits that set true disruptors apart, and the red flags that suggest hype over substance. They also cover how to assess competitive moats, and what metrics matter when profitability hasn't quite yet arrived.Of course, it wouldn't be an episode of Buy Hold Sell without some stock ideas, so the guests each share an ASX innovator that is underrated and the market might be missing, as well as the best innovator ac","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/innovation-or-illusion-how-to-spot-the-real-disruptors-and-4-asx-ideas-for-your-trouble","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/innovation-or-illusion-how-to-spot-the-real-disruptors-and-4-asx-ideas-for-your-trouble","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["BBN.AU","BK7016","BK7001","BK7023","BK7501","COH.AU","SKS.AU","XRO.AU","BK7007","JBH.AU","BK7126","DUG.AU","BK7503","RMD.AU","NAN.AU","BK7128"],"gpt_icon":0},{"id":"2566928581","title":"Schroders warn of frothy markets despite ASX highs","url":"https://stock-news.laohu8.com/highlight/detail?id=2566928581","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566928581?lang=en_us&edition=fundamental","pubTime":"2025-09-12 13:40","pubTimestamp":1757655635,"startTime":"0","endTime":"0","summary":"August delivered one of the more remarkable months for Australian investors. Despite another season of patchy earnings - including disappointing results from blue-chip stalwarts such as CSL Limited  and James Hardie  - the ASX smashed through 9,000 points, rising 3% in the month. Small caps performed even better.At first glance, this strength might suggest a market underpinned by robust fundamentals. But as Martin Conlon, Head of Australian Equities at Schroders, and his deputy Andrew Fleming point out, the reality is very different.Momentum investing and quant-driven strategies are dictating short-term price moves, while fundamentals are often relegated to the back seat. For patient investors, this may be unsettling - but it also creates opportunity.In Schroder's webinarBroadcast Australian Equities: It's only a flesh wound, Conlon and Fleming unpack the sharp share price swings seen during reporting season. They separate justified moves from overreactions, highlight opportunities ari","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/schroders-warn-of-frothy-markets-despite-asx-highs","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/schroders-warn-of-frothy-markets-despite-asx-highs","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["BK7135","BK7507","WOW.AU","BK7067","BK7130","CBA.AU","ORG.AU","XJO.AU","BXB.AU","BK7064","BK7508","BK7044","BK7511","BK7006","CSL.AU","BK7082","BK7007","XKO.AU","BK7040","BK7501","RMD.AU","COL.AU","XAO.AU","JHX.AU"],"gpt_icon":0},{"id":"2566947598","title":"ASX reporting season: Margins, misses, and market opportunities","url":"https://stock-news.laohu8.com/highlight/detail?id=2566947598","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566947598?lang=en_us&edition=fundamental","pubTime":"2025-09-12 12:06","pubTimestamp":1757649998,"startTime":"0","endTime":"0","summary":"First Sentier Investors' David Wilsonand Christian Guerra unpack August’s reporting season — the most volatile on record. From banks and insurers to industrials and hidden tech plays, they explore what moved the market and why volatility might be here to stay.With me today is  Christian Guerra, Head of Research for the Australian Equities Growth Team, and David Wilson, Deputy Head of the Team and Portfolio Manager for one of the longest running Australian Geared Equity Strategies. Welcome, Christian and David.The other thing that we thought was really pleasing was that dividends actually beat expectations by about 15%, and that was a combination of both stronger earnings as well as modestly higher payout ratios. We also saw special dividends from the likes of JB HiFi , Wesfarmers and Qantas . Now having said that, I did use the word encouraging. We probably just need to temper our enthusiasm a little bit, and I say that for two key reasons. Fi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/asx-reporting-season-margins-misses-and-market-opportunities","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/asx-reporting-season-margins-misses-and-market-opportunities","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["BK7030","BK7067","BK7094","BK7001","CSL.AU","IAG.AU","BK7501","BK7082","WTC.AU","XAO.AU","QAN.AU","BK7064","BK7130","RMD.AU","BK7044","WOW.AU","JBH.AU","BK7006","BK7040","ORG.AU","BK7007","BK7016","BK7034","SHL.AU","SUN.AU","BK7124","BK7511","BK7508","XJO.AU","BK7507","XKO.AU","QBE.AU","BK7153","BK7503","COL.AU","BXB.AU","PME.AU","BK7041","WES.AU","JHX.AU"],"gpt_icon":0},{"id":"2566991147","title":"ResMed Inc. Stock Rises Thursday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2566991147","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566991147?lang=en_us&edition=fundamental","pubTime":"2025-09-12 04:53","pubTimestamp":1757623980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of ResMed Inc.  advanced 1.53% to $274.61 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.85% to 6,587.47 and the Dow Jones Industrial Average  rising 1.36% to 46,108.00.The stock's rise snapped a two-day losing streak.ResMed Inc. closed 6.53% short of its 52-week high of $293.81, which the company reached on August 22nd.Trading volume  remained 296,192 below its 50-day average volume of 1.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 11, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RMD","RMD.AU"],"gpt_icon":0},{"id":"2566987536","title":"ResMed Inc. Stock Falls Wednesday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2566987536","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566987536?lang=en_us&edition=fundamental","pubTime":"2025-09-11 04:52","pubTimestamp":1757537520,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of ResMed Inc.  slid 3.12% to $270.47 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index  rising 0.30% to 6,532.04 and the Dow Jones Industrial Average  falling 0.48% to 45,490.92.This was the stock's second consecutive day of losses.ResMed Inc. closed 7.94% below its 52-week high of $293.81, which the company achieved on August 22nd.Trading volume  eclipsed its 50-day average volume of 1.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 10, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RMD.AU","RMD"],"gpt_icon":0},{"id":"2566658973","title":"ResMed CEO Sells $2.2 Million in Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2566658973","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566658973?lang=en_us&edition=fundamental","pubTime":"2025-09-09 06:47","pubTimestamp":1757371641,"startTime":"0","endTime":"0","summary":"ResMed  Chief Executive Michael Farrell sold 8,009 of his shares in the company on the New York Stock Exchange, with an aggregate market value of about $2.2 million, according to a Tuesday filing with the Australian bourse.Following the transaction, Farrell owns nearly 146.4 million shares and other units outstanding in the company, per the filing.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4548","LU2177674079.SGD","BK4504","RMD.AU","XAO.AU","BK4082","RMD","XKO.AU","BK7501","LU0170899867.USD","BK4588","XJO.AU","IE00B5TLWC47.USD","BK4567","LU2008162690.USD","BK7007","BK4585"],"gpt_icon":0},{"id":"2565588792","title":"ResMed Inc. Stock Rises Thursday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2565588792","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565588792?lang=en_us&edition=fundamental","pubTime":"2025-09-05 04:53","pubTimestamp":1757019180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of ResMed Inc.  rallied 1.71% to $273.81 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.83% to 6,502.08 and the Dow Jones Industrial Average  rising 0.77% to 45,621.29.The stock's rise snapped a seven-day losing streak.ResMed Inc. closed 6.81% below its 52-week high of $293.81, which the company achieved on August 22nd.Trading volume  eclipsed its 50-day average volume of 1.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 4, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RMD.AU","RMD"],"gpt_icon":0},{"id":"2564310392","title":"ResMed Starts Clinical Insights Initiative to Understand Sleep Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2564310392","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564310392?lang=en_us&edition=fundamental","pubTime":"2025-09-04 07:09","pubTimestamp":1756940997,"startTime":"0","endTime":"0","summary":"ResMed (ASX:RMD) started its clinical insight program, Sleep Institute, to promote data-driven understanding of sleep health, according to a Thursday statement by the company.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4504","BK4567","IE00B5TLWC47.USD","BK4082","RMD.AU","BK4588","BK7501","BK7007","LU0170899867.USD","LU2177674079.SGD","RMD","LU2008162690.USD","BK4585","BK4548"],"gpt_icon":0},{"id":"2564903853","title":"ResMed on Track for Longest Losing Streak Since May 2022 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2564903853","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564903853?lang=en_us&edition=fundamental","pubTime":"2025-09-04 00:10","pubTimestamp":1756915800,"startTime":"0","endTime":"0","summary":"ResMed Inc.  is currently at $265.83, down $5.16 or 1.9%. --Would be lowest close since July 21, 2025, when it closed at $261.07. --Currently down seven consecutive days; down 9.5% over this period. --Longest losing streak since May 3, 2022, when it fell for nine straight trading days. --Worst seven day stretch since the seven days ending July 1, 2024, when it fell 12.35%. --Down 10.6% from its all-time closing high of $297.36 on Sept. 8, 2021. --Up 8.61% from 52 weeks ago , when it closed at $244.75. --Down 9.5% from its 52-week closing high of $293.73 on Aug. 22, 2025. --Up 29.96% from its 52-week closing low of $204.54 on April 8, 2025. --Traded as low as $265.76; lowest intraday level since July 22, 2025, when it hit $261.06","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK7007","RMD.AU","LU0170899867.USD","BK4567","BK4588","BK4082","LU2177674079.SGD","RMD","BK7501","LU2008162690.USD","BK4585","IE00B5TLWC47.USD","BK4504"],"gpt_icon":0},{"id":"2564339634","title":"ResMed CFO Sells Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2564339634","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564339634?lang=en_us&edition=fundamental","pubTime":"2025-09-03 06:50","pubTimestamp":1756853447,"startTime":"0","endTime":"0","summary":"ResMed (ASX:RMD) Chief Financial Officer Brett Sandercock sold 3,000 shares on the New York Stock Exchange for $812,310 in total, according to a Wednesday filing with the Australian bourse.Following the sale of shares, Sandercock owns 146.4 million shares in the company, per the filing.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RMD","RMD.AU","BK7501","BK4588","LU2177674079.SGD","BK7007","BK4504","XJO.AU","XKO.AU","IE00B5TLWC47.USD","LU0170899867.USD","LU2008162690.USD","BK4082","BK4567","BK4585","BK4548","XAO.AU"],"gpt_icon":0},{"id":"2564333529","title":"ResMed Inc. Stock Falls Tuesday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2564333529","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564333529?lang=en_us&edition=fundamental","pubTime":"2025-09-03 04:53","pubTimestamp":1756846380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of ResMed Inc.  shed 1.28% to $270.99 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.69% to 6,415.54 and Dow Jones Industrial Average  falling 0.55% to 45,295.81.This was the stock's sixth consecutive day of losses.ResMed Inc. closed 7.77% short of its 52-week high of $293.81, which the company reached on August 22nd.Trading volume  eclipsed its 50-day average volume of 998,962.Data source: Dow Jones Market Data, FactSet. Data compiled September 2, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RMD.AU","RMD"],"gpt_icon":0},{"id":"2563061811","title":"ResMed Inc. Stock Falls Thursday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2563061811","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563061811?lang=en_us&edition=fundamental","pubTime":"2025-08-29 04:54","pubTimestamp":1756414440,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of ResMed Inc.  slipped 2.33% to $275.38 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.32% to 6,501.86 and the Dow Jones Industrial Average  rising 0.16% to 45,636.90.This was the stock's fourth consecutive day of losses.ResMed Inc. closed 6.27% short of its 52-week high of $293.81, which the company achieved on August 22nd.Trading volume  eclipsed its 50-day average volume of 972,565.Data source: Dow Jones Market Data, FactSet. Data compiled August 28, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RMD.AU","RMD"],"gpt_icon":0},{"id":"2562783382","title":"ResMed Inc. Stock Falls Monday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2562783382","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562783382?lang=en_us&edition=fundamental","pubTime":"2025-08-26 04:52","pubTimestamp":1756155120,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of ResMed Inc.  shed 2.70% to $285.80 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.43% to 6,439.32 and Dow Jones Industrial Average  falling 0.77% to 45,282.47.ResMed Inc. closed 2.73% below its 52-week high of $293.81, which the company achieved on August 22nd.Trading volume  remained 104,291 below its 50-day average volume of 950,598.Data source: Dow Jones Market Data, FactSet. Data compiled August 25, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RMD.AU","RMD"],"gpt_icon":0},{"id":"2561348434","title":"ResMed Inc. Stock Rises Wednesday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2561348434","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561348434?lang=en_us&edition=fundamental","pubTime":"2025-08-21 04:52","pubTimestamp":1755723120,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of ResMed Inc.  rallied 1.06% to $289.06 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 0.04% to 44,938.31 and the S&P 500 Index  falling 0.24% to 6,395.78.ResMed Inc. closed 1.37% below its 52-week high of $293.08, which the company achieved on August 4th.Trading volume  remained 140,336 below its 50-day average volume of 952,828.Data source: Dow Jones Market Data, FactSet. Data compiled August 20, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RMD.AU","RMD"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":60,"code":"91000000","status":"200"}]}}